Biliopancreatic diversion
- PMID: 9717419
- DOI: 10.1007/s002689900497
Biliopancreatic diversion
Abstract
Biliopancreatic diversion (BPD) has made reacceptable the malabsorptive approach to the surgical treatment of obesity. The procedure, in a series of 2241 patients operated on during a 21-year period, caused a mean permanent reduction of about 75% of the initial excess weight. The indefinite weight maintenance appears to be due to the existence of a threshold absorption capacity for fat and starch, and thus energy, and the weight loss is partly due to increased resting energy expenditure. Beneficial effects other than those consequent to weight loss or reduced nutrient absorption included permanent normalization of serum glucose and cholesterol without any medication and on totally free diet in 100% of cases, both phenomena being due to a specific action of the operation. Operative mortality was less than 0.5%. Specific late complications included anemia, less than 5% with adequate iron or folate supplementation (or both); stomal ulcer, reduced to 3.2% by oral H2-blocker prophylaxis; bone demineralization, increasing up to the fourth year and tending to decrease thereafter, with need of calcium and vitamin D supplementation; neurologic complications, totally avoidable by prompt vitamin B administration to patients at risk; protein malnutrition, which was reduced to a minimum of 3% with 1.3% recurrence, in exchange with a smaller weight loss, by adapting the volume of the gastric remnant and the length of the alimentary limb to the patient's individual characteristics. It is concluded that the correct use of BPD, based on the knowledge of its mechanisms of action, can make the procedure an effective, safe one in all hands.
Similar articles
-
Laparoscopic Reversal of the Biliopancreatic Diversion with Duodenal Switch: a Step by Step Video Case.Obes Surg. 2017 Dec;27(12):3327-3329. doi: 10.1007/s11695-017-2945-6. Obes Surg. 2017. PMID: 28965167
-
Biliopancreatic diversion for obesity at eighteen years.Surgery. 1996 Mar;119(3):261-8. doi: 10.1016/s0039-6060(96)80111-5. Surgery. 1996. PMID: 8619180
-
Biliopancreatic Diversion for Severe Obesity: Long-Term Effectiveness and Nutritional Complications.Obes Surg. 2016 Jan;26(1):38-44. doi: 10.1007/s11695-015-1719-2. Obes Surg. 2016. PMID: 25982805
-
Revision and reversal after biliopancreatic diversion for excessive side effects or ineffective weight loss: a review of the current literature on indications and procedures.Surg Obes Relat Dis. 2015 Jul-Aug;11(4):965-72. doi: 10.1016/j.soard.2015.01.015. Epub 2015 Jan 28. Surg Obes Relat Dis. 2015. PMID: 25726366 Review.
-
Biliopancreatic diversion in the surgical treatment of morbid obesity.World J Surg. 2004 May;28(5):435-44. doi: 10.1007/s00268-004-7364-x. Epub 2004 Apr 19. World J Surg. 2004. PMID: 15085390 Review.
Cited by
-
Update on obesity surgery.World J Gastroenterol. 2006 May 28;12(20):3196-203. doi: 10.3748/wjg.v12.i20.3196. World J Gastroenterol. 2006. PMID: 16718839 Free PMC article. Review.
-
Incidence of Diabetes Mellitus, Cardiovascular Diseases, and Cancer in Patients Undergoing Malabsorptive Surgery (Biliopancreatic Diversion and Biliointestinal Bypass) vs Medical Treatment.Obes Surg. 2019 Mar;29(3):935-942. doi: 10.1007/s11695-018-3601-5. Obes Surg. 2019. PMID: 30448983
-
Prospective evaluation of biliopancreatic diversion with Roux-en-Y gastric bypass in the super obese.J Gastrointest Surg. 2004 May-Jun;8(4):479-88. doi: 10.1016/j.gassur.2003.11.022. J Gastrointest Surg. 2004. PMID: 15120374 Clinical Trial.
-
Surgical intervention as a strategy for treatment of obesity.Endocrine. 2000 Oct;13(2):213-30. doi: 10.1385/ENDO:13:2:213. Endocrine. 2000. PMID: 11186223 Review.
-
Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery.J Gastrointest Surg. 2004 Jan;8(1):48-55; discussion 54-5. doi: 10.1016/j.gassur.2003.09.020. J Gastrointest Surg. 2004. PMID: 14746835
MeSH terms
LinkOut - more resources
Full Text Sources
Medical